Weil Reps Sanofi On $125M Biotech Venture With VCs

Law360, New York (January 10, 2012, 4:56 PM EST) -- French pharmaceutical giant Sanofi SA has partnered with two U.S.-based venture capital firms in a joint investment in biotechnology startup Warp Drive Bio LLC for as much as $125 million, Sanofi announced Tuesday.

Sanofi said it partnered with Third Rock Ventures LLC and Greylock Partners to launch Warp Drive, a genomic search engine business. Sanofi will provide half of the financing, with the VC firms contributing the other half.

Of the total investment, $75 million will be invested in equity in Warp Drive, Sanofi said. Total...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.